Jacobio Pharmaceuticals Group Co., Ltd.

SEHK:1167 Stock Report

Market Cap: HK$1.3b

Jacobio Pharmaceuticals Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:1167 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Oct 23BuyHK$98,784Yinxiang WangIndividual33,600HK$2.94
04 Oct 23BuyHK$594,107Yinxiang WangIndividual198,300HK$3.00
03 Oct 23BuyHK$170,491Yinxiang WangIndividual57,300HK$2.98
29 Sep 23BuyHK$291,713Yinxiang WangIndividual95,700HK$3.05
04 May 23BuyHK$1,004,145Yinxiang WangIndividual150,000HK$6.69
03 May 23BuyHK$529,912Yinxiang WangIndividual79,800HK$6.64
02 May 23BuyHK$361,705Yinxiang WangIndividual53,400HK$6.77

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1167?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,500,0001.07%
Institutions46,419,5025.86%
Employee Share Scheme48,862,2806.17%
Public Companies87,486,89011%
Individual Insiders153,789,47019.4%
VC/PE Firms189,970,89024%
General Public256,726,04832.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 67.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.6%
Yinxiang Wang
107,552,075HK$181.8m0%no data
11.1%
Center Laboratories, Inc.
87,486,890HK$147.9m0%no data
10.3%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
81,827,555HK$138.3m0%1.92%
7.18%
Hillhouse Investment Management, Ltd.
56,861,110HK$96.1m0%0.07%
6.48%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
51,282,225HK$86.7m0%1.81%
3.86%
Willgenpharma LImited
30,590,000HK$51.7m0%no data
2.94%
Yunyan Hu
23,292,295HK$39.4m0%no data
2.9%
Xiaojie Wang
22,945,100HK$38.8m-30.4%no data
2.31%
Gloryviewpharma Ltd
18,272,280HK$30.9m0%no data
1.94%
E Fund Management Co., Ltd.
15,324,188HK$25.9m0%no data
1.76%
The Vanguard Group, Inc.
13,903,800HK$23.5m0.9%no data
1.07%
Blesspharma Ltd
8,500,000HK$14.4m0%no data
0.67%
Bosera Asset Management Co., Ltd.
5,291,100HK$8.9m0%0.01%
0.32%
GF Fund Management Co., Ltd.
2,555,100HK$4.3m0%no data
0.31%
HSBC Jintrust Fund Management Company Limited
2,433,600HK$4.1m0%0.02%
0.21%
BlackRock, Inc.
1,686,600HK$2.9m107%no data
0.12%
Dimensional Fund Advisors LP
978,191HK$1.7m25.1%no data
0.11%
Orient Fund Management Co. Ltd.
896,700HK$1.5m0%0.01%
0.061%
China Merchants Fund Management Company Ltd.
484,800HK$819.3k0%no data
0.059%
China Universal Asset Management Company Ltd.
468,900HK$792.4k0%no data
0.058%
State Street Global Advisors, Inc.
460,390HK$778.1k-5.13%no data
0.047%
HuaAn Fund Management Company Ltd.
369,600HK$624.6k-39.7%no data
0.036%
Huashang Fund Management Company Ltd.
285,600HK$482.6k0%no data
0.035%
Candriam
274,438HK$463.8k0%no data
0.034%
Guotai Asset Management Company Limited
270,381HK$456.9k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.